J S Johansen Selected Research

Interleukin 1 Receptor Antagonist Protein (Anakinra)

10/2005

Magnetic resonance imaging for accelerated assessment of drug effect and prediction of subsequent radiographic progression in rheumatoid arthritis: a study of patients receiving combined anakinra and methotrexate treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

J S Johansen Research Topics

Disease

8	Rheumatoid Arthritis 01/2019 - 04/2001
6	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 10/2013
6	Neoplasms (Cancer) 01/2019 - 07/2006
5	Inflammation (Inflammations) 02/2013 - 04/2001
2	Infections 10/2020 - 05/2005
2	Necrosis 07/2013 - 02/2008
2	Fibrosis (Cirrhosis) 07/2005 - 06/2000
2	Osteoarthritis 04/2001 - 04/2001
1	Urinary Tract Infections (Urinary Tract Infection) 10/2020
1	Sepsis (Septicemia) 10/2020
1	Bacterial Pneumonia 10/2020
1	Pancreatic Diseases (Pancreatic Disease) 01/2019
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Rectal Neoplasms (Rectal Cancer) 01/2018
1	Frailty 06/2017
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2016
1	Disease Progression 12/2016
1	Liver Diseases (Liver Disease) 12/2016
1	Alcoholic Liver Diseases (Alcoholic Liver Disease) 12/2016
1	Lymphoma (Lymphomas) 12/2016
1	Multiple Myeloma 12/2016
1	Rheumatic Diseases (Rheumatism) 09/2016
1	Psoriatic Arthritis 07/2013
1	Psoriasis (Pustulosis Palmaris et Plantaris) 07/2013
1	Carcinoma (Carcinomatosis) 07/2006
1	Ovarian Neoplasms (Ovarian Cancer) 07/2006
1	Ovarian Epithelial Carcinoma 07/2006
1	Insulin Resistance 02/2006
1	Type 2 Diabetes Mellitus (MODY) 02/2006
1	Synovitis 10/2005
1	Liver Cirrhosis (Hepatic Cirrhosis) 06/2003
1	Chronic Hepatitis C 06/2003

Drug/Important Bio-Agent (IBA)

12	Biomarkers (Surrogate Marker)IBA 01/2019 - 04/2001
5	C-Reactive ProteinIBA 10/2020 - 02/2006
4	Interleukin-6 (Interleukin 6)IBA 01/2019 - 11/2006
4	Methotrexate (Mexate)FDA LinkGeneric 09/2016 - 10/2005
3	Cell-Free Nucleic AcidsIBA 01/2019 - 01/2018
3	Adalimumab (Humira)FDA Link 09/2016 - 07/2013
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2019 - 10/2013
2	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 01/2018
2	Biological ProductsIBA 12/2018 - 04/2016
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 11/2006
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 07/2005 - 04/2001
1	Proteins (Proteins, Gene)FDA Link 12/2016
1	triamcinolone hexacetonide (Aristospan)FDA Link 09/2016
1	Circulating MicroRNAIBA 04/2016
1	Capecitabine (Xeloda)FDA Link 10/2013
1	Angiogenesis InhibitorsIBA 10/2013
1	Bevacizumab (Avastin)FDA Link 10/2013
1	Rituximab (Mabthera)FDA Link 06/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2008
1	EnzymesIBA 02/2008
1	ImmunosorbentsIBA 02/2008
1	Infliximab (Remicade)FDA Link 11/2006
1	Tumor Biomarkers (Tumor Markers)IBA 07/2006
1	PlatinumIBA 07/2006
1	Carboplatin (JM8)FDA LinkGeneric 07/2006
1	Paclitaxel (Taxol)FDA LinkGeneric 07/2006
1	Topotecan (Hycamtin)FDA LinkGeneric 07/2006
1	tetranectinIBA 07/2006
1	Pharmaceutical PreparationsIBA 10/2005
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 10/2005
1	EndotoxinsIBA 05/2005
1	Matrix Metalloproteinases (MMPs)IBA 06/2003
1	Interferon-alpha (Interferon Alfa)IBA 06/2003
1	Antiviral Agents (Antivirals)IBA 06/2003
1	procollagen Type III-N-terminal peptide (PIIP)IBA 06/2003
1	Ribavirin (Virazole)FDA LinkGeneric 06/2003
1	Chitinase-3-Like Protein 1IBA 04/2001
1	CytokinesIBA 04/2001
1	AntigensIBA 06/2000

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 01/2019 - 07/2006
3	Therapeutics 12/2016 - 06/2003
1	Radiotherapy 01/2018
1	Biological Therapy 06/2017
1	Drug Tapering 06/2017
1	Treatment Delay 06/2017
1	Cell Transplantation 12/2016
1	Adjuvant Chemotherapy 01/2016
1	Replacement Arthroplasty 04/2001